Dr Greg Collier, Managing Director and CEO of Invion (IVX), has more than 20 years experience spanning operational, clinical and scientific aspects of pharmaceutical research, development and commercialisation. He has led the planning and execution of multiple commercial transactions including in and out licensing deals and major M&A activities, and he has successfully taken a drug from discovery through to regulatory approval.
Greg provided our network with an update on Invion (IVX) on Monday, 4 August 2014. You can watch an excerpt from the presentation below:
Dr Greg Collier, Invion (IVX)
If you are interested in finding out more about Invion (IVX), please contact your adviser or nearest Morgans office
Our research is complimentary for all Morgans clients. Contact us if you are interested in becoming a client and accessing our research.
Print this page